American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Q2 2024 EPS Estimates for ACADIA Pharmaceuticals Inc. Decreased by HC Wainwright (NASDAQ:ACAD)

Q2 2024 EPS Estimates for ACADIA Pharmaceuticals Inc. Decreased by HC Wainwright (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Investment analysts at HC Wainwright decreased their Q2 2024 EPS estimates for ACADIA Pharmaceuticals in a research note issued to investors on Thursday, May... More of this article »
Image about Q2 2024 EPS Estimates for American Public Education, Inc. (NASDAQ:APEI) Lifted by William Blair

Q2 2024 EPS Estimates for American Public Education, Inc. (NASDAQ:APEI) Lifted by William Blair

American Public Education, Inc. (NASDAQ:APEI – Free Report) – Research analysts at William Blair raised their Q2 2024 earnings per share (EPS) estimates for shares of American Public Education in a note issued to investors... More of this article »
Image about AppLovin Co. (NASDAQ:APP) Forecasted to Earn Q2 2024 Earnings of $0.71 Per Share

AppLovin Co. (NASDAQ:APP) Forecasted to Earn Q2 2024 Earnings of $0.71 Per Share

AppLovin Co. (NASDAQ:APP – Free Report) – William Blair boosted their Q2 2024 earnings per share (EPS) estimates for AppLovin in a research note issued on Wednesday, May 8th. William Blair analyst R. Schackart now anticipates... More of this article »
Image about Leerink Partnrs Weighs in on agilon health, inc.’s Q2 2024 Earnings (NYSE:AGL)

Leerink Partnrs Weighs in on agilon health, inc.’s Q2 2024 Earnings (NYSE:AGL)

agilon health, inc. (NYSE:AGL – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q2 2024 earnings per share (EPS) estimates for shares of agilon health in a research note issued on Wednesday,... More of this article »
Image about a.k.a. Brands Holding Corp. (NYSE:AKA) Expected to Earn Q2 2024 Earnings of ($0.23) Per Share

a.k.a. Brands Holding Corp. (NYSE:AKA) Expected to Earn Q2 2024 Earnings of ($0.23) Per Share

a.k.a. Brands Holding Corp. (NYSE:AKA – Free Report) – Investment analysts at Telsey Advisory Group boosted their Q2 2024 earnings per share (EPS) estimates for a.k.a. Brands in a research note issued on Thursday, May... More of this article »
Image about Arhaus, Inc. (NASDAQ:ARHS) Forecasted to Post Q2 2024 Earnings of $0.13 Per Share

Arhaus, Inc. (NASDAQ:ARHS) Forecasted to Post Q2 2024 Earnings of $0.13 Per Share

Arhaus, Inc. (NASDAQ:ARHS – Free Report) – William Blair lowered their Q2 2024 earnings estimates for Arhaus in a report issued on Thursday, May 9th. William Blair analyst P. Blee now forecasts that the company will... More of this article »
Image about Q2 2024 Earnings Estimate for Agnico Eagle Mines Limited Issued By Zacks Research (NYSE:AEM)

Q2 2024 Earnings Estimate for Agnico Eagle Mines Limited Issued By Zacks Research (NYSE:AEM)

Agnico Eagle Mines Limited (NYSE:AEM – Free Report) (TSE:AEM) – Equities research analysts at Zacks Research raised their Q2 2024 earnings per share (EPS) estimates for Agnico Eagle Mines in a research note issued to... More of this article »
Image about Agenus Inc. Expected to Post Q2 2024 Earnings of ($0.02) Per Share (NASDAQ:AGEN)

Agenus Inc. Expected to Post Q2 2024 Earnings of ($0.02) Per Share (NASDAQ:AGEN)

Agenus Inc. (NASDAQ:AGEN – Free Report) – B. Riley boosted their Q2 2024 earnings per share (EPS) estimates for Agenus in a research report issued to clients and investors on Wednesday, May 8th. B. Riley analyst M.... More of this article »
Image about Q2 2024 EPS Estimates for Aclaris Therapeutics, Inc. Boosted by Analyst (NASDAQ:ACRS)

Q2 2024 EPS Estimates for Aclaris Therapeutics, Inc. Boosted by Analyst (NASDAQ:ACRS)

Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – HC Wainwright raised their Q2 2024 earnings per share (EPS) estimates for Aclaris Therapeutics in a report issued on Wednesday, May 8th. HC Wainwright analyst... More of this article »
Image about Avadel Pharmaceuticals plc Forecasted to Post Q2 2024 Earnings of ($0.20) Per Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc Forecasted to Post Q2 2024 Earnings of ($0.20) Per Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Analysts at Lifesci Capital issued their Q2 2024 earnings estimates for Avadel Pharmaceuticals in a report released on Wednesday, May 8th. Lifesci Capital analyst... More of this article »
Image about Noble Financial Weighs in on Beasley Broadcast Group, Inc.’s Q2 2024 Earnings (NASDAQ:BBGI)

Noble Financial Weighs in on Beasley Broadcast Group, Inc.’s Q2 2024 Earnings (NASDAQ:BBGI)

Beasley Broadcast Group, Inc. (NASDAQ:BBGI – Free Report) – Noble Financial dropped their Q2 2024 earnings per share (EPS) estimates for Beasley Broadcast Group in a research report issued to clients and investors on... More of this article »
Image about National Bank Financial Weighs in on Atlantica Sustainable Infrastructure plc’s Q2 2024 Earnings (NASDAQ:AY)

National Bank Financial Weighs in on Atlantica Sustainable Infrastructure plc’s Q2 2024 Earnings (NASDAQ:AY)

Atlantica Sustainable Infrastructure plc (NASDAQ:AY – Free Report) – Stock analysts at National Bank Financial upped their Q2 2024 earnings per share estimates for Atlantica Sustainable Infrastructure in a report released... More of this article »
Image about Brokers Offer Predictions for Apellis Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:APLS)

Brokers Offer Predictions for Apellis Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:APLS)

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at HC Wainwright increased their Q2 2024 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a research note issued on Wednesday,... More of this article »
Image about Zacks Research Comments on AptarGroup, Inc.’s Q2 2024 Earnings (NYSE:ATR)

Zacks Research Comments on AptarGroup, Inc.’s Q2 2024 Earnings (NYSE:ATR)

AptarGroup, Inc. (NYSE:ATR – Free Report) – Zacks Research boosted their Q2 2024 EPS estimates for shares of AptarGroup in a research report issued to clients and investors on Thursday, May 9th. Zacks Research analyst... More of this article »
Image about Astria Therapeutics, Inc. (NASDAQ:ATXS) Forecasted to Post Q2 2024 Earnings of ($0.40) Per Share

Astria Therapeutics, Inc. (NASDAQ:ATXS) Forecasted to Post Q2 2024 Earnings of ($0.40) Per Share

Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Equities researchers at Lifesci Capital issued their Q2 2024 earnings per share (EPS) estimates for Astria Therapeutics in a research note issued to investors on... More of this article »